TREATMENT OF OSTEOPOROSIS WITH BISPHOSPHONATES-Reference-Cited by-同舟云学术

TREATMENT OF OSTEOPOROSIS WITH BISPHOSPHONATES

Published:1994-08 Issue:3 Volume:20 Page:717-734
ISSN:0889-857X
Container-title:Rheumatic Disease Clinics of North America
language:en
Short-container-title:Rheumatic Disease Clinics of North America

Author:

Watts Nelson B.

Publisher

Elsevier BV

Subject

Rheumatology

Reference127 articles.

1. Adachi JD, Bensen WG, Bianchi F, et al: Intermittent cyclic etidronate therapy (ICT) prevents corticosteroid-induced bone loss [abstract]. In Programs and Abstracts of the Fourth International Symposium on Osteoporosis, Hong Kong, 1993, p 434

2. Intermittent cyclic etidronate therapy (ICT) prevents corticosteroid-induced bone loss [abstract];Adachi;J Bone Miner Res,1993

3. The acute phase response after bisphosphonate administration;Adami;Calcif Tissue Int,1987

4. Influence of disodium etidronate on clinical and laboratory manifestations of Paget’s disease of bone (osteitis deformans);Altman;N Engl J Med,1973

5. Preliminary observations of a form of coherence therapy for osteoporosis;Anderson;Calcif Tissue Int,1984

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of DNA damage in postmenopausal women under osteoporosis therapy;European Journal of Obstetrics & Gynecology and Reproductive Biology;2006-08

2. Oral Bisphosphonates to Treat Disuse Osteopenia in Children With Disabilities;Journal of Pediatric Orthopaedics;2005-05

3. The Effect of Clodronate on the Integrity and Viability of Rat Small Intestine in Vitro-A Comparison with EDTA;Biological and Pharmaceutical Bulletin;2005

4. Hip Fracture Prevention in Postmenopausal Women;Obstetrical & Gynecological Survey;2004-06

5. Bisphosphonate mucosal injury—the end of the story?;Digestive and Liver Disease;2003-02